We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Testing Personalized Treatments in 5 days With 3D

News   May 22, 2019 | Original story from University of Geneva (UNIGE)

 
Testing Personalized Treatments in 5 days With 3D

Representative image of 3D model of colorectal carcinoma (HCT116 cells) exposed for 72 hours to treatment with a three-drug combination containing regorafenib, erlotinib and 5-fluorouracil. The cell-tracker stained cells correspond to cell nuclei (blue), live cells (green) and dead cells (red). © UNIGE, Molecular Pharmacology Group

 
 
 

RELATED ARTICLES

Chemists’ Success in Synthesis Drives Development of Anti-cancer Agent

News

Researchers have now synthesized sufficient quantities of E7130, a drug candidate from the halichondrin class, to enable for the first time rigorous studies of its biological activity, pharmacological properties, and efficacy.

READ MORE

A Piece to the Puzzle of Brain Stem Cell Activation

News

Molecules form a complex called STRIPAK, which is essential for the promotion of neural stem cell reactivation, and for switching off dormancy.

READ MORE

Discovery Could Help Treat People With Cardiovascular Disease

News

Researchers have found a link between a peptide called apelin and a reduction of abdominal aortic aneurysms that was shown to dramatically reduce mortality in mice. They are using this knowledge to develop a new medical therapy to treat cardiovascular disease.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Cancer Research Cell Science

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE